Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Sound waves aimed at the brain could ease seizures

NCT ID NCT07353918

First seen Jun 24, 2026 · Last updated Jun 24, 2026

Summary

This small study tests whether low-intensity focused ultrasound (LIFU) can safely reduce seizures in people with temporal lobe epilepsy that doesn't improve with medication. Six participants with implanted brain electrodes will receive both real and sham ultrasound sessions. The main goal is to see if seizure frequency changes, and researchers will also track side effects and symptoms.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for EPILEPSY (TREATMENT REFRACTORY) are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • Fralin Biomedical Research Institute at VTC

    Roanoke, Virginia, 24016, United States

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

Low-intensity focused ultrasound (LIFU) device

What this could lead to

If it works, this could point toward a non-invasive way to reduce seizures in people with epilepsy that doesn't respond to medication.

What could go wrong

This is a very early, tiny study with only 6 people. It's invite-only and uses a sham comparison, so results may not apply widely or show clear benefit.

Conditions

The condition(s) this trial relates to.

epilepsy visual epilepsy

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.